María José Díaz Valentín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
María José Díaz Valentín has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- María José Simón Saiz
Department of Nursing, University of Castilla-La Mancha, 16071 Cuenca, Spain
3 shared publications - Rosa María Fuentes Chacón
Department of Nursing, University of Castilla-La Mancha, Cuenca, Spain
3 shared publications - Margarita Garrido-Abejar
Department of Nursing, University of Castilla-La Mancha, Cuenca, Spain
2 shared publications - María Dolores Serrano-Parra
Faculty of Nursing, University of Castilla-La Mancha, Cuenca, Spain
2 shared publications - Santiago Yubero
Universidad de Castilla-La Mancha
2 shared publications - Alicia Saz-Lara
CarVasCare Research Group, Instituto de Biomedicina, Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16071 Cuenca, Spain
1 shared publication
Latest Publications
- Open Access
- 7 August 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1923
Effect of Remote Ischemic Preconditioning Evaluated by Nurses on Improvement of Arterial Stiffness, Endothelial Function, Diastolic Function, and Exercise Capacity in Patients with Heart Failure with Preserved Ejection Fraction (PIRIC-FEp Study): Protocol for Randomised Controlled Trial
Background/Objectives: Heart failure with preserved ejection fraction (HFpEF) has increased in prevalence as the population ages and associated comorbidities increase. Remote ischemic preconditioning (RIPC) has been shown to provide protection against ischemic injury to the heart and other organs. Therefore, the aim of this project will be to analyse the effectiveness of RIPC in terms of arterial stiffness, endothelial function, diastolic function, and exercise capacity in patients with HFpEF. Methods: The PIRIC-FEp study will be a parallel, randomised controlled trial with two groups conducted at the Faculty of Nursing in Cuenca, University of Castilla-La Mancha. Individuals who are diagnosed with HFpEF and are older than 40 years, with a left ventricular ejection fraction ≥50% and a sedentary lifestyle, will be included. The exclusion criteria will include, among others, patients with noncardiac causes of heart failure symptoms, significant pulmonary disease, diabetes, peripheral vascular disease, or myocardial infarction within the previous three months. A sample size of 48 patients was estimated, with 24 for each group. Participants will be randomly allocated (1:1) to either the RIPC intervention group or the control group to evaluate the effects on arterial stiffness, endothelial function, diastolic function, and exercise capacity. Assessments will be conducted at baseline and after a three-month follow-up period. Results: The findings will be published in a peer-reviewed journal article. Conclusions: This study is important for daily clinical practice because it provides a new approach for the treatment of HFpEF patients via RIPC.
- 7 August 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1923
Open AccessEffect of Remote Ischemic Preconditioning Evaluated by Nurses on Improvement of Arterial Stiffness, Endothelial Function, Diastolic Function, and Exercise Capacity in Patients with Heart Failure with Preserved Ejection Fraction (PIRIC-FEp Study): Protocol for Randomised Controlled Trial
Background/Objectives: Heart failure with preserved ejection fraction (HFpEF) has increased in prevalence as the population ages and associated comorbidities increase. Remote ischemic preconditioning (RIPC) has been shown to provide protection against ischemic injury to the heart and other organs. Therefore, the aim of this project will be to analyse the effectiveness of RIPC in terms of arterial stiffness, endothelial function, diastolic function, and exercise capacity in patients with HFpEF. Methods: The PIRIC-FEp study will be a parallel, randomised controlled trial with two groups conducted at the Faculty of Nursing in Cuenca, University of Castilla-La Mancha. Individuals who are diagnosed with HFpEF and are older than 40 years, with a left ventricular ejection fraction ≥50% and a sedentary lifestyle, will be included. The exclusion criteria will include, among others, patients with noncardiac causes of heart failure symptoms, significant pulmonary disease, diabetes, peripheral vascular disease, or myocardial infarction within the previous three months. A sample size of 48 patients was estimated, with 24 for each group. Participants will be randomly allocated (1:1) to either the RIPC intervention group or the control group to evaluate the effects on arterial stiffness, endothelial function, diastolic function, and exercise capacity. Assessments will be conducted at baseline and after a three-month follow-up period. Results: The findings will be published in a peer-reviewed journal article. Conclusions: This study is important for daily clinical practice because it provides a new approach for the treatment of HFpEF patients via RIPC.
- 1 January 2020
- Published by Elsevier in Medicina de Familia. SEMERGEN
- Vol. 46 (1) , 33-40
Perfil de consumo de drogas en adolescentes. Factores protectores
- 1 January 2020
- Published by Elsevier in Medicina de Familia. SEMERGEN
- Vol. 46 (1) , 33-40
Perfil de consumo de drogas en adolescentes. Factores protectores
- 1 October 2019
- Published by Elsevier in Nurse Education in Practice
- Vol. 40, 102629
Validation to the Spanish of the Jefferson empathy scale health professions students version and its psychometric properties in nursing students
- 1 October 2019
- Published by Elsevier in Nurse Education in Practice
- Vol. 40, 102629
Validation to the Spanish of the Jefferson empathy scale health professions students version and its psychometric properties in nursing students
- 1 June 2017
- Published by Elsevier in Applied Nursing Research
- Vol. 35, 112-117
The impact of biological frailty syndrome on quality of life of nursing home residents
- 1 June 2017
- Published by Elsevier in Applied Nursing Research
- Vol. 35, 112-117
The impact of biological frailty syndrome on quality of life of nursing home residents